The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.

about

The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.

Item

http://www.wikidata.org/entity/Q36402306

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The impact of bismuth addition ...... ri eradication: A pilot study.

@ast

The impact of bismuth addition ...... ri eradication: A pilot study.

@en

type

Item

label

The impact of bismuth addition ...... ri eradication: A pilot study.

@ast

The impact of bismuth addition ...... ri eradication: A pilot study.

@en

prefLabel

The impact of bismuth addition ...... ri eradication: A pilot study.

@ast

The impact of bismuth addition ...... ri eradication: A pilot study.

@en

P1476

The impact of bismuth addition ...... ri eradication: A pilot study.

@en

P2093

Abdullah Ozgür Yeniova

http://www.w3.org/2001/XMLSchema#string

Ayse Kefeli

http://www.w3.org/2001/XMLSchema#string

Ferdane Sapmaz

http://www.w3.org/2001/XMLSchema#string

Metin Uzman

http://www.w3.org/2001/XMLSchema#string

Murat Hokkaomeroglu

http://www.w3.org/2001/XMLSchema#string

Sebahat Basyigit

http://www.w3.org/2001/XMLSchema#string

Yasar Nazligul

http://www.w3.org/2001/XMLSchema#string

Zeliha Asilturk

http://www.w3.org/2001/XMLSchema#string

P2860

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Sequential therapy versus standard triple therapy in Helicobacter pylori eradication in a high clarithromycin resistance setting.

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

Therapy of Helicobacter pylori.

Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.

Bismuth compounds in medicinal chemistry.

Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis.

P304

50-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.17305/BJBMS.2015.573

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283582609

http://www.w3.org/2001/XMLSchema#string

P698

26614852

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

4690442

http://www.w3.org/2001/XMLSchema#string